FDA Investigator: Brooke K. Higgins
- Brooke K. Higgins first started conducting FDA inspections in 2002, with the last inspection in 2014. Over that time, Brooke K. Higgins has conducted 222 inspections at 137 companies across 139 sites.
Get Brooke Higgins's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Afton Scientific, Charlottesville | April 2014
Available Now - $199
Brooke K. Higgins
Human Drug Form 483
FDA 483 Cangene bioPharma, . dba Emergent BioSolution | 2014
Available Now - $199
Brooke K. Higgins
Human Drug Form 483
FDA 483 Mylan Pharmaceuticals, Morgantown | March 2014
Available Now - $199
Brooke K. Higgins
Human Drug Form 483
FDA 483 Fareva Richmond, Henrico | March 2014
Available Now - $199
Brooke K. Higgins
Human Drug Form 483
FDA 483 RX South DBA RX3 Compounding Pharmacy | Feb 2014
Available Now - $199
Brooke K. Higgins
Animal Drugs & Feed Form 483
FDA 483 Lowlite Investments, . D/B/A Olympia Pharmacy | 2013
Available Now - $199
Brooke K. Higgins
Animal Drugs & Feed Form 483
FDA 483 Fresenius Medical Care de Mexico, Zapopan | 2013
Out-of-stock
Brooke K. Higgins
Human Drug Form 483
FDA 483 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Elkton | 2013
Out-of-stock
Brooke K. Higgins
Human Drug Form 483
FDA 483 Barr Laboratories, Inc. (div. Of Teva), Forest | 2013
Out-of-stock
Brooke K. Higgins
Human Drug Form 483
FDA 483 Bell-More Laboratories Inc, Hampstead | 2013
Out-of-stock
Brooke K. Higgins
Human Drug Form 483
FDA 483 Afton Scientific, LLC, Charlottesville | 2013
Out-of-stock
Brooke K. Higgins
Human Drug Form 483
FDA 483 United Therapeutics Corporation, Silver Spring | 2013
Out-of-stock
Brooke K. Higgins
Human Drug Form 483
FDA 483 Fareva Richmond, Inc., Henrico | 2013
Out-of-stock
Brooke K. Higgins
Human Drug Form 483
FDA 483 Teva Biopharmaceuticals USA, Rockville | 2013
Out-of-stock
Brooke K. Higgins
Human Drug Form 483
FDA 483 Precision Nuclear of Virginia, LLC, Salem | 2013
Out-of-stock
Brooke K. Higgins
Human Drug Form 483
FDA 483 PETNET Solutions, Inc., Charlottesville | 2013
Out-of-stock
Brooke K. Higgins
Human Drug Form 483
FDA 483 IBA Molecular, Sterling | 2013
Out-of-stock
Brooke K. Higgins
Human Drug Form 483
FDA 483 Orion Corporation, Espoo | 2012
Out-of-stock
Brooke K. Higgins
Animal Drugs & Feed Form 483
Co-Investigators (43)
- Clarice J. Ahn, FDA Investigator
- Jonathan W. Chapman, FDA Investigator
- Paula J. Bretz, FDA Investigator
- Ana P. Pineda Zavaleta, FDA Investigator
- Pineda Zavaleta, Ana P, FDA Investigator
- Rachel C. Harrington, FDA Investigator
- Dianne H. Milazzo, FDA Investigator
- Brian R. Yaun, FDA Investigator
- Patricia A. Morrow, FDA Investigator
- Joanne E. King, FDA Investigator
- Caryn M. McNab, FDA Investigator
- Carrie L. Doupnik, FDA Investigator
- Nebil A. Oumer, FDA Investigator
- Sam Pepe, FDA Investigator
- Ernest Bizjak, FDA Investigator
- William A. Warnick, FDA Investigator
- Emmanuel A. Dimaano, FDA Investigator
- Tammara A. Stephens, FDA Investigator
- Merideth K. Rose, FDA Investigator
- Gifford Whitehurst, FDA Investigator
- Joey C. West, FDA Investigator
- Stacey A. Priest, FDA Investigator
- Latoya S. Oliver-Powell, FDA Investigator
- Erin L. McFiren, FDA Investigator
- Luis M. Burgos Medero, FDA Investigator
- Burgos Medero, Luis M, FDA Investigator
- Lori S. Lawless, FDA Investigator
- William H. Linkroum, FDA Investigator
- Monique-Rac Lester, FDA Investigator
- Jose R. Hernandez, FDA Investigator
- Kenneth Nieves, FDA Investigator
- Dennis Cantellops Paite, FDA Investigator
- Cantellops Paite, Dennis, FDA Investigator
- Melissa J. Garcia, FDA Investigator
- Douglas A. Campbell, FDA Investigator
- Walter L. Fava, FDA Investigator
- Kenneth M. Gordon, FDA Investigator
- Candice C. Mandera, FDA Investigator
- Luella J. Rossi, FDA Investigator
- Lawrence Harmon, FDA Investigator
- Ronald T. Nowalk, FDA Investigator
- Wayne L. Jefferson, FDA Investigator
- Wilfred A. Darang, FDA Investigator